Latest stories on MNKD
MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026 | MNKD Stock News
StockTitan50 · neutralearnings
FDA Approves Mannkind's At-Home Treatment Option for Heart Failure or Kidney Disease
Yahoo Top73 · bullishproduct/pr
H.C. Wainwright reiterates MannKind stock rating on FDA approval
Investing.com Analyst Ratings63 · neutralanalyst
MannKind Raises $50 Million in Private Placement
TipRanks24 · bearishgeneral
MANNKIND CORP (MNKD) files 8-K
SEC 8-K50 · neutralgeneral
MNKD Stock Rises 8% On Furoscix ReadyFlow Approval And $50M Funding Boost
Stocktwits News68 · bullishproduct/pr
MannKind Corporation (MNKD) Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic Therapy in Fluid Overload Transcript
Seeking Alpha73 · bullishproduct/pr
MannKind shares surge after FDA approves Furoscix ReadyFlow and company secures $50 million financing
InvestorsHub71 · bullishproduct/pr
H.C. Wainwright reiterates Buy on MannKind stock ahead of PDUFA
Investing.com Analyst Ratings61 · neutralanalyst
Why is MannKind stock rallying today?
Investing.com Markets50 · neutralgeneral
At a glance: stocks gapping up premarket
Seeking Alpha50 · neutralgeneral
MannKind stock jumps 6% on FDA approval, $50M financing
Investing.com Markets68 · bullishgeneral
MannKind shares rise on announcing $50M private placement financing
Seeking Alpha28 · bearishgeneral
MannKind Announces $50 Million Private Placement
Business Insider24 · bearishgeneral
MannKind Announces $50 Million Private Placement | MNKD Stock News
StockTitan24 · bearishgeneral
MNKD Stock Rises Premarket As FDA Verdict Nears – Retail Optimism Builds
Stocktwits News63 · neutralgeneral
What This MannKind Filing Reveals About Three Years of Underperformance
Yahoo Finance38 · neutralgeneral
What This MannKind Director Sale Signals With $32.7 Million in Quarterly Royalties Revenue Potentially at Risk
Yahoo Top38 · neutralgeneral
What This MannKind Sale Signals With Tyvaso Royalties at $32.7 Million
Yahoo Finance50 · neutralgeneral
What This MannKind Filing Reveals About Three Years of Underperformance
The Motley Fool38 · neutralgeneral
What This MannKind Director Sale Signals With $32.7 Million in Quarterly Royalties Revenue Potentially at Risk
The Motley Fool38 · neutralgeneral
Why This MannKind Insider Stock Sale Matters Less Than a 9% Royalty at Risk
Yahoo Top52 · neutralgeneral
What This MannKind Sale Signals With Tyvaso Royalties at $32.7 Million
The Motley Fool50 · neutralgeneral